Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Salmonella Infections | 2 | 2018 | 82 | 1.38 | Why? |
| Cat-Scratch Disease | 2 | 2018 | 17 | 0.94 | Why? |
| Abortion, Septic | 1 | 2018 | 5 | 0.79 | Why? |
| Fanconi Syndrome | 1 | 2018 | 12 | 0.77 | Why? |
| Bronchogenic Cyst | 1 | 2018 | 4 | 0.77 | Why? |
| Mycosis Fungoides | 1 | 2019 | 48 | 0.75 | Why? |
| Retroperitoneal Fibrosis | 1 | 2018 | 20 | 0.73 | Why? |
| Salmonella | 1 | 2018 | 58 | 0.73 | Why? |
| Exanthema | 2 | 2019 | 1097 | 0.72 | Why? |
| Olea | 1 | 2017 | 20 | 0.70 | Why? |
| Nephritis, Interstitial | 1 | 2018 | 83 | 0.70 | Why? |
| Carcinoma, Ductal, Breast | 1 | 2019 | 149 | 0.69 | Why? |
| Hereditary Autoinflammatory Diseases | 1 | 2018 | 72 | 0.68 | Why? |
| Red Meat | 1 | 2017 | 39 | 0.68 | Why? |
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2018 | 229 | 0.66 | Why? |
| Seeds | 1 | 2017 | 114 | 0.66 | Why? |
| Splenectomy | 1 | 2017 | 85 | 0.66 | Why? |
| Debridement | 1 | 2018 | 172 | 0.66 | Why? |
| Erythema Nodosum | 1 | 2017 | 38 | 0.65 | Why? |
| Thyrotoxicosis | 1 | 2017 | 59 | 0.65 | Why? |
| Contraceptive Agents | 1 | 2017 | 62 | 0.64 | Why? |
| Soft Tissue Infections | 1 | 2018 | 116 | 0.64 | Why? |
| Leg | 1 | 2017 | 142 | 0.61 | Why? |
| Uveitis | 1 | 2018 | 233 | 0.59 | Why? |
| Cardiac Tamponade | 1 | 2018 | 165 | 0.59 | Why? |
| Hepatitis | 1 | 2017 | 160 | 0.58 | Why? |
| Intestinal Obstruction | 1 | 2017 | 197 | 0.56 | Why? |
| Lymph Nodes | 2 | 2019 | 1060 | 0.56 | Why? |
| Intestine, Small | 1 | 2017 | 336 | 0.55 | Why? |
| Foreign Bodies | 1 | 2017 | 171 | 0.54 | Why? |
| Meningococcal Infections | 1 | 2017 | 216 | 0.54 | Why? |
| Lymphadenopathy | 1 | 2018 | 444 | 0.47 | Why? |
| Urticaria | 1 | 2018 | 472 | 0.46 | Why? |
| Pancreatic Neoplasms | 1 | 2019 | 609 | 0.46 | Why? |
| Fever | 3 | 2017 | 7795 | 0.46 | Why? |
| Lymphohistiocytosis, Hemophagocytic | 1 | 2017 | 800 | 0.38 | Why? |
| Positron Emission Tomography Computed Tomography | 2 | 2018 | 1458 | 0.38 | Why? |
| Non-alcoholic Fatty Liver Disease | 1 | 2018 | 907 | 0.36 | Why? |
| Autoimmune Diseases | 2 | 2021 | 1996 | 0.35 | Why? |
| Shock, Septic | 1 | 2017 | 1313 | 0.33 | Why? |
| Liver Neoplasms | 1 | 2019 | 1666 | 0.33 | Why? |
| Pregnancy Complications | 1 | 2017 | 1388 | 0.31 | Why? |
| Ceftriaxone | 2 | 2018 | 365 | 0.31 | Why? |
| Skin Neoplasms | 1 | 2019 | 1679 | 0.29 | Why? |
| Diagnosis, Differential | 4 | 2019 | 7220 | 0.26 | Why? |
| Blood Coagulation Disorders | 1 | 2017 | 2040 | 0.26 | Why? |
| Breast Neoplasms | 1 | 2019 | 3633 | 0.21 | Why? |
| Anti-Bacterial Agents | 7 | 2019 | 10083 | 0.21 | Why? |
| Common Bile Duct | 1 | 2019 | 21 | 0.20 | Why? |
| Salmonella enteritidis | 1 | 2018 | 10 | 0.20 | Why? |
| Biopsy | 2 | 2019 | 2811 | 0.20 | Why? |
| Chorioamnionitis | 1 | 2018 | 50 | 0.19 | Why? |
| Retroperitoneal Space | 1 | 2019 | 68 | 0.19 | Why? |
| Amoxicillin-Potassium Clavulanate Combination | 1 | 2018 | 72 | 0.19 | Why? |
| Kidney Tubules, Proximal | 1 | 2020 | 178 | 0.19 | Why? |
| Pain | 2 | 2017 | 1084 | 0.19 | Why? |
| Groin | 1 | 2018 | 22 | 0.19 | Why? |
| Aerococcus | 1 | 2018 | 3 | 0.19 | Why? |
| Paclitaxel | 1 | 2019 | 124 | 0.18 | Why? |
| Trastuzumab | 1 | 2019 | 108 | 0.18 | Why? |
| Postoperative Complications | 1 | 2017 | 5861 | 0.18 | Why? |
| Discitis | 1 | 2018 | 23 | 0.18 | Why? |
| Liver Abscess, Amebic | 1 | 2017 | 8 | 0.18 | Why? |
| Entamoebiasis | 1 | 2017 | 10 | 0.18 | Why? |
| Obesity | 2 | 2019 | 7388 | 0.17 | Why? |
| Jaundice | 1 | 2019 | 114 | 0.17 | Why? |
| Cardiotoxicity | 1 | 2021 | 365 | 0.17 | Why? |
| Acute Kidney Injury | 1 | 2017 | 5762 | 0.16 | Why? |
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2019 | 237 | 0.16 | Why? |
| Dermatomyositis | 1 | 2018 | 193 | 0.15 | Why? |
| Administration, Topical | 1 | 2017 | 272 | 0.15 | Why? |
| Erectile Dysfunction | 1 | 2017 | 141 | 0.15 | Why? |
| Exercise Tolerance | 1 | 2021 | 634 | 0.15 | Why? |
| Tomography, X-Ray Computed | 4 | 2021 | 25144 | 0.15 | Why? |
| Immunologic Tests | 1 | 2018 | 445 | 0.14 | Why? |
| Bone and Bones | 1 | 2017 | 235 | 0.14 | Why? |
| Necrosis | 1 | 2018 | 532 | 0.14 | Why? |
| Plasma Cells | 1 | 2018 | 464 | 0.14 | Why? |
| Cats | 2 | 2018 | 1890 | 0.14 | Why? |
| Belgium | 4 | 2021 | 2064 | 0.13 | Why? |
| Humans | 30 | 2021 | 930598 | 0.13 | Why? |
| Weight Loss | 1 | 2019 | 826 | 0.13 | Why? |
| Transcription Factors | 1 | 2018 | 784 | 0.12 | Why? |
| Pregnancy Complications, Infectious | 1 | 2018 | 11559 | 0.12 | Why? |
| Female | 15 | 2021 | 380317 | 0.12 | Why? |
| Exercise Therapy | 1 | 2021 | 976 | 0.12 | Why? |
| Telerehabilitation | 1 | 2021 | 736 | 0.12 | Why? |
| Steroids | 1 | 2017 | 904 | 0.11 | Why? |
| Recovery of Function | 1 | 2021 | 2461 | 0.11 | Why? |
| Fatal Outcome | 1 | 2019 | 3438 | 0.10 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 1573 | 0.09 | Why? |
| Male | 16 | 2021 | 367725 | 0.09 | Why? |
| Adult | 10 | 2020 | 244371 | 0.09 | Why? |
| Young Adult | 6 | 2019 | 93724 | 0.09 | Why? |
| Pain Management | 1 | 2017 | 854 | 0.09 | Why? |
| Home Care Services | 1 | 2019 | 1351 | 0.09 | Why? |
| Hematologic Neoplasms | 1 | 2020 | 2105 | 0.08 | Why? |
| Autoantibodies | 1 | 2018 | 2094 | 0.08 | Why? |
| Critical Illness | 2 | 2021 | 17281 | 0.08 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2017 | 1261 | 0.08 | Why? |
| Aged | 10 | 2021 | 215776 | 0.08 | Why? |
| Skin | 1 | 2018 | 2096 | 0.08 | Why? |
| Middle Aged | 11 | 2021 | 270681 | 0.08 | Why? |
| Pregnancy | 2 | 2018 | 23879 | 0.07 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.07 | Why? |
| Bacterial Infections | 1 | 2019 | 2229 | 0.07 | Why? |
| Azithromycin | 1 | 2020 | 3943 | 0.07 | Why? |
| Psoriasis | 1 | 2019 | 1739 | 0.07 | Why? |
| Acute Disease | 1 | 2017 | 6029 | 0.07 | Why? |
| Immunocompromised Host | 1 | 2021 | 5150 | 0.07 | Why? |
| Intensive Care Units | 2 | 2021 | 29594 | 0.07 | Why? |
| Wounds and Injuries | 1 | 2017 | 1708 | 0.07 | Why? |
| Palliative Care | 1 | 2019 | 2665 | 0.07 | Why? |
| Genetic Predisposition to Disease | 1 | 2018 | 4027 | 0.06 | Why? |
| Polymerase Chain Reaction | 1 | 2018 | 6740 | 0.06 | Why? |
| Ultrasonography | 1 | 2019 | 4409 | 0.06 | Why? |
| Hydroxychloroquine | 3 | 2021 | 12447 | 0.06 | Why? |
| Ambulatory Care | 1 | 2019 | 4947 | 0.06 | Why? |
| Risk Factors | 3 | 2020 | 71621 | 0.06 | Why? |
| Nervous System Diseases | 1 | 2020 | 4092 | 0.06 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.06 | Why? |
| Prospective Studies | 3 | 2021 | 43301 | 0.06 | Why? |
| Radiographic Image Enhancement | 1 | 2021 | 89 | 0.05 | Why? |
| Gangliosides | 1 | 2020 | 86 | 0.05 | Why? |
| Spinal Puncture | 1 | 2020 | 95 | 0.05 | Why? |
| Radiculopathy | 1 | 2020 | 79 | 0.05 | Why? |
| Bone Diseases, Infectious | 1 | 2019 | 20 | 0.05 | Why? |
| Respiratory Insufficiency | 1 | 2021 | 7301 | 0.05 | Why? |
| Prostatitis | 1 | 2019 | 18 | 0.05 | Why? |
| Liver Abscess | 1 | 2019 | 42 | 0.05 | Why? |
| Cystitis | 1 | 2019 | 45 | 0.05 | Why? |
| Wound Infection | 1 | 2019 | 66 | 0.05 | Why? |
| Pyelonephritis | 1 | 2019 | 66 | 0.05 | Why? |
| Dysentery, Amebic | 1 | 2017 | 6 | 0.04 | Why? |
| Leukocytosis | 1 | 2020 | 280 | 0.04 | Why? |
| Bartonella henselae | 1 | 2017 | 28 | 0.04 | Why? |
| Cholangitis | 1 | 2019 | 81 | 0.04 | Why? |
| Entamoeba histolytica | 1 | 2017 | 22 | 0.04 | Why? |
| Nerve Tissue Proteins | 1 | 2020 | 319 | 0.04 | Why? |
| Aged, 80 and over | 4 | 2020 | 88759 | 0.04 | Why? |
| Mutation | 1 | 2018 | 12376 | 0.04 | Why? |
| Arthritis, Infectious | 1 | 2019 | 111 | 0.04 | Why? |
| Metronidazole | 1 | 2017 | 59 | 0.04 | Why? |
| Neurologic Examination | 1 | 2020 | 428 | 0.04 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2019 | 9335 | 0.04 | Why? |
| Cholecystitis | 1 | 2019 | 141 | 0.04 | Why? |
| Antiprotozoal Agents | 1 | 2017 | 83 | 0.04 | Why? |
| Penis | 1 | 2017 | 101 | 0.04 | Why? |
| Electromyography | 1 | 2018 | 278 | 0.04 | Why? |
| Fever of Unknown Origin | 1 | 2017 | 93 | 0.04 | Why? |
| Hospital Mortality | 1 | 2020 | 22087 | 0.04 | Why? |
| Catheterization, Peripheral | 1 | 2019 | 249 | 0.04 | Why? |
| Tacrolimus | 1 | 2018 | 435 | 0.04 | Why? |
| Positron-Emission Tomography | 1 | 2021 | 802 | 0.04 | Why? |
| Administration, Intravenous | 1 | 2019 | 1115 | 0.04 | Why? |
| Doxycycline | 1 | 2017 | 307 | 0.04 | Why? |
| Diabetic Foot | 1 | 2019 | 317 | 0.03 | Why? |
| Retrospective Studies | 3 | 2021 | 105322 | 0.03 | Why? |
| Methotrexate | 1 | 2018 | 471 | 0.03 | Why? |
| Linear Models | 1 | 2021 | 1914 | 0.03 | Why? |
| Erythema | 1 | 2018 | 400 | 0.03 | Why? |
| Gram-Positive Bacterial Infections | 1 | 2018 | 323 | 0.03 | Why? |
| Drug Eruptions | 1 | 2018 | 319 | 0.03 | Why? |
| Drainage | 1 | 2017 | 414 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2021 | 1755 | 0.03 | Why? |
| Antibodies | 1 | 2020 | 846 | 0.03 | Why? |
| Endocarditis | 1 | 2019 | 368 | 0.03 | Why? |
| Treatment Failure | 1 | 2019 | 2106 | 0.03 | Why? |
| Encephalitis | 1 | 2020 | 797 | 0.03 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.03 | Why? |
| Follow-Up Studies | 2 | 2021 | 17020 | 0.03 | Why? |
| Testis | 1 | 2017 | 566 | 0.03 | Why? |
| Treatment Outcome | 4 | 2021 | 51732 | 0.03 | Why? |
| Lung | 1 | 2021 | 31049 | 0.03 | Why? |
| Animals | 2 | 2018 | 78931 | 0.03 | Why? |
| Abdominal Pain | 1 | 2017 | 858 | 0.03 | Why? |
| Adolescent | 2 | 2019 | 86841 | 0.03 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2019 | 1115 | 0.03 | Why? |
| Delirium | 1 | 2020 | 1061 | 0.03 | Why? |
| Fatigue | 1 | 2021 | 2479 | 0.03 | Why? |
| Convalescence | 1 | 2021 | 2829 | 0.02 | Why? |
| Membrane Proteins | 1 | 2020 | 1733 | 0.02 | Why? |
| Patient Readmission | 1 | 2019 | 1543 | 0.02 | Why? |
| Lupus Erythematosus, Systemic | 1 | 2021 | 1380 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.02 | Why? |
| Body Mass Index | 1 | 2021 | 4306 | 0.02 | Why? |
| Methylprednisolone | 1 | 2018 | 2107 | 0.02 | Why? |
| Dyspnea | 1 | 2021 | 3847 | 0.02 | Why? |
| Pilot Projects | 1 | 2019 | 5182 | 0.02 | Why? |
| Early Detection of Cancer | 1 | 2018 | 1956 | 0.02 | Why? |
| Patient Satisfaction | 1 | 2019 | 2517 | 0.02 | Why? |
| Survival Rate | 1 | 2020 | 9206 | 0.02 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.02 | Why? |
| Adrenal Cortex Hormones | 1 | 2021 | 6537 | 0.02 | Why? |
| France | 1 | 2020 | 12074 | 0.02 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.02 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2021 | 10649 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Case-Control Studies | 1 | 2020 | 17671 | 0.01 | Why? |
| Length of Stay | 1 | 2019 | 11042 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Immunosuppressive Agents | 1 | 2018 | 6331 | 0.01 | Why? |
| Anti-Inflammatory Agents | 1 | 2018 | 6153 | 0.01 | Why? |
| Respiratory Tract Infections | 1 | 2019 | 6817 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Prognosis | 1 | 2020 | 32490 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2019 | 8207 | 0.01 | Why? |
| Child, Preschool | 1 | 2019 | 36283 | 0.01 | Why? |
| Child | 1 | 2019 | 70012 | 0.01 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.00 | Why? |
Yildiz's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(213)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(82)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_